Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Chewy Launches Compounded Medications for Pets, Plans to Offer it as a Service to Veterinarians in Future


Chewy, Inc. (“Chewy”) (NYSE: CHWY), the leader in pet e-commerce, announced today that it is expanding its Pharmacy (Rx) business to now offer compounded medications that are customized to the specific needs of pets.

The launch of compounding medications comes on the heels of Chewy’s newly debuted “Connect With a Vet” telehealth service and advances the company’s mission to be the most trusted resource for pet parents and veterinarians.

“Building off our relationship with both pet parents and veterinarians, Chewy is uniquely positioned to make pet healthcare more accessible and affordable for every American household,” said Mita Malhotra, Vice President of Healthcare at Chewy. “By making these types of medications more widely available, we want to better serve pet parents who need a customized solution in an otherwise limited marketplace.”

In addition to the existing broad selection of pharmacy products, this compounded offering from Chewy provides pet owners the ability to order customized, pharmaceutical grade, prescription medications that meet their pets’ unique needs, that cannot be fulfilled by commercially available alternatives.

Chewy Pharmacy’s compounding ingredients are sourced from FDA-registered manufacturers and distributors, and all customized medications are prepared by licensed compounding pharmacists, to the specifications requested by the veterinarian. Customers can order from Chewy in the same way they do their other medications and will receive the same great service, speed and convenience. In the future, the company plans to expand its offering to veterinarians who can utilize the service to provide compounded medication options to their in-clinic customers.

About Chewy

Our mission is to be the most trusted and convenient online destination for pet parents (and partners) everywhere. We believe that we are the preeminent online source for pet products, supplies and prescriptions as a result of our broad selection of high-quality products, which we offer at competitive prices and deliver with an exceptional level of care and a personal touch. We continually develop innovative ways for our customers to engage with us, and partner with more than 2,000 of the best and most trusted brands in the pet industry, to bring a high-bar, customer-centric experience to our customers.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201112005323/en/

Chewy Inc Stock

€14.75
-6.080%
Heavy losses for Chewy Inc today as the stock fell by -€0.948 (-6.080%).
With 30 Buy predictions and 3 Sell predictions Chewy Inc is one of the favorites of our community.
As a result the target price of 28 € shows a very positive potential of 89.86% compared to the current price of 14.75 € for Chewy Inc.
Like: 0
Share
Business Wire, a Berkshire Hathaway company, is the global leader in press release distribution and regulatory disclosure. Investor relations, public relations, public policy and marketing professionals rely on Business Wire for secure and accurate distribution of market-moving news and multimedia.

Legal notice

Comments